Mackenzie W. Amoroso
Columbia University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Mackenzie W. Amoroso.
Cell | 2011
Christoph Bock; Evangelos Kiskinis; Griet Verstappen; Hongcang Gu; Gabriella L. Boulting; Zachary D. Smith; Michael J. Ziller; Gist F. Croft; Mackenzie W. Amoroso; Derek Oakley; Andreas Gnirke; Kevin Eggan; Alexander Meissner
The developmental potential of human pluripotent stem cells suggests that they can produce disease-relevant cell types for biomedical research. However, substantial variation has been reported among pluripotent cell lines, which could affect their utility and clinical safety. Such cell-line-specific differences must be better understood before one can confidently use embryonic stem (ES) or induced pluripotent stem (iPS) cells in translational research. Toward this goal we have established genome-wide reference maps of DNA methylation and gene expression for 20 previously derived human ES lines and 12 human iPS cell lines, and we have measured the in vitro differentiation propensity of these cell lines. This resource enabled us to assess the epigenetic and transcriptional similarity of ES and iPS cells and to predict the differentiation efficiency of individual cell lines. The combination of assays yields a scorecard for quick and comprehensive characterization of pluripotent cell lines.
Nature Biotechnology | 2011
Gabriella L. Boulting; Evangelos Kiskinis; Gist F. Croft; Mackenzie W. Amoroso; Derek Oakley; Brian J. Wainger; Damian J. Williams; David J. Kahler; Mariko Yamaki; Lance S. Davidow; Christopher T Rodolfa; John T. Dimos; Shravani Mikkilineni; Amy B. MacDermott; Clifford J. Woolf; Christopher E. Henderson; Hynek Wichterle; Kevin Eggan
Human induced pluripotent stem cells (iPSCs) present exciting opportunities for studying development and for in vitro disease modeling. However, reported variability in the behavior of iPSCs has called their utility into question. We established a test set of 16 iPSC lines from seven individuals of varying age, sex and health status, and extensively characterized the lines with respect to pluripotency and the ability to terminally differentiate. Under standardized procedures in two independent laboratories, 13 of the iPSC lines gave rise to functional motor neurons with a range of efficiencies similar to that of human embryonic stem cells (ESCs). Although three iPSC lines were resistant to neural differentiation, early neuralization rescued their performance. Therefore, all 16 iPSC lines passed a stringent test of differentiation capacity despite variations in karyotype and in the expression of early pluripotency markers and transgenes. This iPSC and ESC test set is a robust resource for those interested in the basic biology of stem cells and their applications.
The Journal of Neuroscience | 2013
Mackenzie W. Amoroso; Gist F. Croft; Damian J. Williams; Sean O'Keeffe; Monica A. Carrasco; Anne R. Davis; Laurent Roybon; Derek Oakley; Tom Maniatis; Christopher E. Henderson; Hynek Wichterle
Human pluripotent stem cells are a promising source of differentiated cells for developmental studies, cell transplantation, disease modeling, and drug testing. However, their widespread use even for intensely studied cell types like spinal motor neurons is hindered by the long duration and low yields of existing protocols for in vitro differentiation and by the molecular heterogeneity of the populations generated. We report a combination of small molecules that within 3 weeks induce motor neurons at up to 50% abundance and with defined subtype identities of relevance to neurodegenerative disease. Despite their accelerated differentiation, motor neurons expressed combinations of HB9, ISL1, and column-specific markers that mirror those observed in vivo in human embryonic spinal cord. They also exhibited spontaneous and induced activity, and projected axons toward muscles when grafted into developing chick spinal cord. Strikingly, this novel protocol preferentially generates motor neurons expressing markers of limb-innervating lateral motor column motor neurons (FOXP1+/LHX3−). Access to high-yield cultures of human limb-innervating motor neuron subtypes will facilitate in-depth study of motor neuron subtype-specific properties, disease modeling, and development of large-scale cell-based screening assays.
eLife | 2015
Jeremiah Y. Cohen; Mackenzie W. Amoroso; Naoshige Uchida
Serotonins function in the brain is unclear. One challenge in testing the numerous hypotheses about serotonins function has been observing the activity of identified serotonergic neurons in animals engaged in behavioral tasks. We recorded the activity of dorsal raphe neurons while mice experienced a task in which rewards and punishments varied across blocks of trials. We ‘tagged’ serotonergic neurons with the light-sensitive protein channelrhodopsin-2 and identified them based on their responses to light. We found three main features of serotonergic neuron activity: (1) a large fraction of serotonergic neurons modulated their tonic firing rates over the course of minutes during reward vs punishment blocks; (2) most were phasically excited by punishments; and (3) a subset was phasically excited by reward-predicting cues. By contrast, dopaminergic neurons did not show firing rate changes across blocks of trials. These results suggest that serotonergic neurons signal information about reward and punishment on multiple timescales. DOI: http://dx.doi.org/10.7554/eLife.06346.001
PLOS ONE | 2012
Tomonori Takazawa; Gist F. Croft; Mackenzie W. Amoroso; Lorenz Studer; Hynek Wichterle; Amy B. MacDermott
Our understanding of motor neuron biology in humans is derived mainly from investigation of human postmortem tissue and more indirectly from live animal models such as rodents. Thus generation of motor neurons from human embryonic stem cells and human induced pluripotent stem cells is an important new approach to model motor neuron function. To be useful models of human motor neuron function, cells generated in vitro should develop mature properties that are the hallmarks of motor neurons in vivo such as elaborated neuronal processes and mature electrophysiological characteristics. Here we have investigated changes in morphological and electrophysiological properties associated with maturation of neurons differentiated from human embryonic stem cells expressing GFP driven by a motor neuron specific reporter (Hb9::GFP) in culture. We observed maturation in cellular morphology seen as more complex neurite outgrowth and increased soma area over time. Electrophysiological changes included decreasing input resistance and increasing action potential firing frequency over 13 days in vitro. Furthermore, these human embryonic stem cell derived motor neurons acquired two physiological characteristics that are thought to underpin motor neuron integrated function in motor circuits; spike frequency adaptation and rebound action potential firing. These findings show that human embryonic stem cell derived motor neurons develop functional characteristics typical of spinal motor neurons in vivo and suggest that they are a relevant and useful platform for studying motor neuron development and function and for modeling motor neuron diseases.
The Journal of Neuroscience | 2012
Stephane Nedelec; Mirza Peljto; Peng Shi; Mackenzie W. Amoroso; Lance C. Kam; Hynek Wichterle
Formation of functional motor circuits relies on the ability of distinct spinal motor neuron subtypes to project their axons with high precision to appropriate muscle targets. While guidance cues contributing to motor axon pathfinding have been identified, the intracellular pathways underlying subtype-specific responses to these cues remain poorly understood. In particular, it remains controversial whether responses to axon guidance cues depend on axonal protein synthesis. Using a growth cone collapse assay, we demonstrate that mouse embryonic stem cell-derived spinal motor neurons (ES-MNs) respond to ephrin-A5, Sema3f, and Sema3a in a concentration-dependent manner. At low doses, ES-MNs exhibit segmental or subtype-specific responses, while this selectivity is lost at higher concentrations. Response to high doses of semaphorins and to all doses of ephrin-A5 is protein synthesis independent. In contrast, using microfluidic devices and stripe assays, we show that growth cone collapse and guidance at low concentrations of semaphorins rely on local protein synthesis in the axonal compartment. Similar bimodal response to low and high concentrations of guidance cues is observed in human ES-MNs, pointing to a general mechanism by which neurons increase their repertoire of responses to the limited set of guidance cues involved in neural circuit formation.
Nature Neuroscience | 2016
Ritchie Ho; Samuel Sances; Genevieve Gowing; Mackenzie W. Amoroso; Jacqueline G O'Rourke; Anais Sahabian; Hynek Wichterle; Robert H. Baloh; Dhruv Sareen; Clive N. Svendsen
Modeling amyotrophic lateral sclerosis (ALS) with human induced pluripotent stem cells (iPSCs) aims to reenact embryogenesis, maturation and aging of spinal motor neurons (spMNs) in vitro. As the maturity of spMNs grown in vitro compared to spMNs in vivo remains largely unaddressed, it is unclear to what extent this in vitro system captures critical aspects of spMN development and molecular signatures associated with ALS. Here, we compared transcriptomes among iPSC-derived spMNs, fetal spinal tissues and adult spinal tissues. This approach produced a maturation scale revealing that iPSC-derived spMNs were more similar to fetal spinal tissue than to adult spMNs. Additionally, we resolved gene networks and pathways associated with spMN maturation and aging. These networks enriched for pathogenic familial ALS genetic variants and were disrupted in sporadic ALS spMNs. Altogether, our findings suggest that developing strategies to further mature and age iPSC-derived spMNs will provide more effective iPSC models of ALS pathology.
International Journal of Developmental Neuroscience | 2012
Kevin C. Kanning; Hai Li; Elena Nikulina; Jianwei Hou; Wan S Yang; Artem Kaplan; John R. Bermingham; Nuno J. Lamas; Mackenzie W. Amoroso; Hynek Wichterle; Marie T. Filbin; Brent R. Stockwell; Christopher E. Henderson
Centre for Neuroscience and Florey Neuroscience Institutes, The University of Melbourne, Australia Within the vertebrate central nervous system (CNS) the efficiency and speed of action potentials relies on myelin, a specialized membrane structure formed by oligodendrocytes. Proper establishment and maintenance of myelin is essential for the functioning of the CNS during both development and adult life, as evidenced by diseases such as the leukodystrophies and Multiple Sclerosis. In addition, ongoing myelination in the adult is thought to contribute to neural plasticity and learning. The regulation of myelination is thus a vital feature of both developmental and adult CNS processes. Recently, a number of regulatory mechanisms controlling myelination have been identified. At the extracellular level, these include a series of ligands expressed by neurons and astrocytes as well as neuronal activity itself. Within the oligodendrocyte lineage, recent advances have identified transcriptional and epigenetic pathways that are vital for the generation of myelinating cells. A significant current challenge to the field is to understand how these different levels of regulation interact with and influence each other. We have recently identified a previously uncharacterized transcription factor, Myelin Gene Regulatory Factor (MRF), which is specifically expressed within the brain by myelinating oligodendrocytes. MRF is vital for the process of CNS myelination during development; conditional knockout mice lacking MRF within the oligodendrocyte lineage generate oligodendrocyte progenitors and pre-myelinating oligodendrocytes however these oligodendrocytes are unable to express myelin genes or myelinate adjacent axons. Conversely, forced expression of MRF causes precocious expression of myelin proteins. We have demonstrated via ChIPSeq experiments that MRF acts directly at promoter and enhancer regions of genes encoding the protein components of myelin, as well as cytoskeletal, lipid metabolism and junctional proteins that underpin the myelination process. These findings establish MRF as a central point in the molecular events regulating myelination from which we may be able to understand how the other levels of regulation converge and interact.
Neuron | 2014
Diane B. Re; Virginia Le Verche; Changhao Yu; Mackenzie W. Amoroso; Kristin Politi; Sudarshan Phani; Burcin Ikiz; Lucas Hoffmann; Martijn Koolen; Tetsuya Nagata; Dimitra Papadimitriou; Peter L. Nagy; Hiroshi Mitsumoto; Shingo Kariya; Hynek Wichterle; Christopher E. Henderson; Serge Przedborski
Cell Reports | 2016
Hai Li; Takaaki Kuwajima; Derek Oakley; Elena Nikulina; Jianwei Hou; Wan Seok Yang; Emily Rhodes Lowry; Nuno J. Lamas; Mackenzie W. Amoroso; Gist F. Croft; Raghavendra Hosur; Hynek Wichterle; Said M. Sebti; Marie T. Filbin; Brent R. Stockwell; Christopher E. Henderson